drugset / Trial / NCT07527078
Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes
RandomizedParallel-groupOpen-labelTreatment
Summary
Evaluate the efficacy of GZR33 Injection and Insulin Degludec Injection (Tresiba®) in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Oral Antidiabetic Drugs.
Timeline
- Start
- 2026-04-07
- Primary completion
- 2026-04-07
- Completion
- 2027-04-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GZR33 | Unknown | — | Subcutaneous |
| Comparator | insulin degludec | Protein / enzyme biologic | — | Subcutaneous |